IDEXX Laboratories Inc (NASDAQ:IDXX)

190.27
Delayed Data
As of Dec 14
 -4.70 / -2.41%
Today’s Change
154.88
Today|||52-Week Range
256.22
+21.67%
Year-to-Date

Today’s Trading

Previous close194.97
Today’s open192.98
Day’s range189.58 - 193.75
Volume545,526
Average volume (3 months)511,679
Market cap$16.7B
Data as of 4:00pm ET, 12/14/2018

Growth & Valuation

Earnings growth (last year)+21.46%
Earnings growth (this year)+27.85%
Earnings growth (next 5 years)+18.05%
Revenue growth (last year)+10.91%
P/E ratio51.1
Price/Sales7.11
Price/Book--

Competitors

 Today’s
change
Today’s
% change
IMMUImmunomedics Inc-0.37-1.94%
NEOGNeogen Corp-1.14-1.80%
QDELQuidel Corp-0.81-1.60%
MYGNMyriad Genetics Inc-0.10-0.32%
Data as of 4:00pm ET, 12/14/2018

Financials

Next reporting dateJanuary 31, 2019
EPS forecast (this quarter)$0.90
Annual revenue (last year)$2.0B
Annual profit (last year)$263.1M
Net profit margin13.36%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Jonathan W. Ayers
Chief Financial Officer, Treasurer &
Executive VP
Brian Patrick McKeon
Corporate headquarters
Westbrook, Maine

Forecasts